文献速递关节外科

对报告青霉素和头孢菌素过敏的患者进行术前过敏检测在全膝和全髋关节置换术后感染预防中具有成本效益

Preoperative Allergy Testing for Patients Reporting Penicillin and Cephalosporin Allergies is Cost-Effective in Preventing Infection after Total Knee and Hip Arthroplasty.
PubMed 文献 · J Arthroplasty · 2020-08-27

该研究采用盈亏平衡分析模型,评估对报告青霉素和头孢菌素过敏的全膝/全髋关节置换患者常规术前过敏检测预防感染的成本效益。结果显示,若全膝置换感染率绝对风险降低0.810%(需治疗人数=123)、全髋置换降低0.655%(需治疗人数=153),则该策略具有成本效益,且在不同过敏会诊费用、感染率和假体周围感染治疗费用下成本效益维持。

要点

  • 全膝置换术后感染率绝对风险降低0.810%(需治疗人数=123)时,术前过敏检测具成本效益。
  • 全髋置换术后感染率绝对风险降低0.655%(需治疗人数=153)时,术前过敏检测具成本效益。
  • 在不同过敏会诊费用、感染率和假体周围感染治疗费用下,成本效益维持。

核心结论

  • 对报告青霉素和头孢菌素过敏的择期关节置换患者,常规术前过敏检测和清除是具成本效益的感染预防策略。
  • 广泛采用该做法可能大幅降低假体感染相关的经济和社会负担。

研究设计与样本

  • 研究采用盈亏平衡分析,构建经济模型。
  • 模型参数包括青霉素过敏评估费用、假体周围感染翻修置换费用以及围手术期接受非头孢唑林抗生素患者的假体周围感染基线率,均取自现有文献。
  • 通过模型计算术前过敏检测具成本效益所需的感染率绝对风险降低,并由此计算需治疗人数。

主要发现

  • 全膝置换患者中,若初始感染率绝对风险降低0.810%(需治疗人数=123),术前过敏检测具成本效益。
  • 全髋置换患者中,若初始感染率绝对风险降低0.655%(需治疗人数=153),术前过敏检测具成本效益。
  • 在不同过敏会诊费用、感染率和假体周围感染治疗费用下,成本效益维持。

关键数值与推荐

  • 全膝置换:感染率绝对风险降低0.810%,需治疗人数=123。
  • 全髋置换:感染率绝对风险降低0.655%,需治疗人数=153。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Routine preoperative allergy testing in patients reporting penicillin and cephalosporin allergies increases the number able to receive cefazolin, which should reduce the risk of infection after total knee and hip arthroplasty (TKA/THA), but it remains unclear whether this practice is cost-effective. Using a break-even analysis, we calculated the cost-effectiveness of routine preoperative allergy testing for infection prevention in total joint arthroplasty patients reporting penicillin and cephalosporin allergies. METHODS: The cost of a penicillin allergy evaluation, the cost of revision arthroplasty for prosthetic joint infection (PJI), and baseline rates of PJI in patients receiving a noncefazolin antibiotic in the perioperative period were derived from existing literature. A break-even economic model using these variables was constructed to calculate the absolute risk reduction (ARR) in infection rate needed for preoperative allergy testing to be cost-effective. The number needed to treat (NNT) was calculated from the ARR. RESULTS: Preoperative allergy testing before TKA and THA in patients reporting penicillin and cephalosporin allergies was cost-effective if the initial infection rate decreased by an ARR of 0.810% (NNT = 123) and 0.655% (NNT = 153) for TKA and THA, respectively. Cost-effectiveness was maintained with varying allergy consultation costs, infection rates, and costs associated with PJI treatment. CONCLUSION: Routine preoperative allergy testing and clearance are cost-effective infection prevention strategies among patients reporting penicillin and cephalosporin allergies in the setting of elective joint arthroplasty. Widespread adoption of this practice may considerably reduce the economic and societal burden associated with prosthetic infections.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Pagani NR, Moverman MA, Puzzitiello RN, et al. Preoperative Allergy Testing for Patients Reporting Penicillin and Cephalosporin Allergies is Cost-Effective in Preventing Infection after Total Knee and Hip Arthroplasty. J Arthroplasty. 2020. PMID: 32933797. doi:10.1016/j.arth.2020.08.045

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。